A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/70 (2006.01)
Patent
CA 2244117
The intravenous use of magnesium gluconate to substantially block free radical surge in the treatment of ischemia/reperfusion (I/R) injury due to oxidative stress.
La présente invention concerne l'utilisation du gluconate de magnésium pour bloquer sensiblement la montée du taux de radicaux libres en cas de traitement de lésions d'ischémie ou de reperfusion par suite de stress oxydant.
Deeth Williams Wall Llp
Weglicki William B.
LandOfFree
Intravenous magnesium gluconate for treatment of conditions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intravenous magnesium gluconate for treatment of conditions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intravenous magnesium gluconate for treatment of conditions... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1585335